We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Prophotonix Limited | LSE:PPIX | London | Ordinary Share | COM SHS $0.001 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.75 | 8.50 | 9.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
16/2/2018 12:45 | good to see a bit of interest returning. | greedy rooster | |
02/2/2018 17:30 | POST REMOVED | buywell3 | |
02/2/2018 17:30 | POST REMOVED | buywell3 | |
31/1/2018 18:58 | POST REMOVED | buywell3 | |
31/1/2018 07:59 | With record order book and new products. | greedy rooster | |
31/1/2018 07:36 | ProPhotonix announces its Fiscal 2017 Trading Update ProPhotonix Limited (London Stock Exchange -- AIM: PPIX and PPIR, OTC: STKR), a high technology designer and manufacturer of LED illumination systems and laser diode modules, with operations in Ireland and the United Kingdom, today announces a fiscal 2017 trading update subject to final audit. Revenue for the full year 2017 is expected to be approximately $17.6 million (2016: $16.2 million), a record annual revenue for the group. The revenue split for the two business units is: LED $8.3 million (2016: $6.8 million) and for Lasers $9.3 million (2016: $9.4 million). The revenue growth stems from an increase in sales to several major customers, partially offset by a decrease in sales to one large laser customer that converted to an alternate technology in the second quarter of 2017. The order book as of December 31, 2017, is $7.3 million (2016: $5.6 million), a record backlog for our two business units. The Company has invested in the future growth of the business and implemented a new performance based stock option program for employee incentivization, which has resulted in a significant increase in non-cash compensation charges associated with these stock option grants. The investments include the hiring of additional sales personnel in the fourth quarter of 2016, increased engineering and development costs associated with several large original equipment manufacturing ("OEM") projects, as well as the continuing investment in the UV LED product development. Operating income for the full year 2017 is expected to be approximately $1.0 million (2016: $1.5 million) after accounting for these additional expenses. Excluding the impact of a non-cash stock compensation expense of $0.6 million in 2017 versus $0.2 million in 2016, operating income would have remained approximately flat versus 2016. The Company also expects to report record earnings before interest, taxes, stock--based compensation and impairment charges, depreciation, and amortization (EBITDA), a non-GAAP measure of financial performance, for the full year 2017 of approximately $1.9 million (2016: $1.5 million). | rcturner2 | |
29/1/2018 16:45 | POST REMOVED | buywell3 | |
10/1/2018 17:35 | POST REMOVED | buywell3 | |
10/1/2018 17:33 | POST REMOVED | buywell3 | |
09/1/2018 13:50 | ProPhotonix awarded IDA grant for capital expansion program Investment in UV LED infrastructure to accelerate product line growth ProPhotonix Limited (London Stock Exchange - AIM: PPIX and PPIR, OTC: STKR), a high technology designer and manufacturer of LED illumination systems and laser diode modules, with operations in Ireland and the United Kingdom, is pleased to announce that it has been awarded a major capital grant to fund an advanced dedicated UV LED curing systems manufacturing line in its Cork facility. The substantial grant is being funded by the Irish Development Authority Ireland ("IDA") through its Business Asset Program, which supports the growth of new manufacturing capability and capacity in Ireland. Customer interest in the COBRA Cure(TM) FX series of UV LED curing systems has exceeded the Company's expectations. In order to support the expected future volume of shipments, ProPhotonix is developing a new state-of-the-art UV LED lamp production line, which will form part of this IDA backed capital expenditure program. Tim Losik, Chief Executive Officer of the Company, stated: "The Company has invested heavily in developing our UV LED curing products, resulting in a series of product range extensions over the last two years. Due to significant customer interest in these products, we continue to invest in UV LED product development and in specialist manufacturing capability in Ireland and in our laser business in the United Kingdom. The Company plans a total capital expenditure in 2018 of approximately US$500,000 with further increases in capital spending expected in future years to support anticipated market demand from the maturing markets for our products." | greedy rooster | |
08/1/2018 10:02 | Grant award and encouraging news re UV Curing. | greedy rooster | |
20/12/2017 11:24 | We got a trading update on the 19th Dec last year. Will we see one tomorrow before the Christmas break...? Friday will only be a good day to put out less than positive news, so let's hope we see something tomorrow. | skirbell | |
20/12/2017 08:09 | Photonics division of IQE up 100% compared with last year. | greedy rooster | |
16/11/2017 09:00 | Added a few more this week | greedy rooster | |
01/11/2017 19:30 | POST REMOVED | buywell3 | |
06/10/2017 09:47 | Good call. | greedy rooster | |
05/10/2017 08:29 | I picked up another 75k this am. | rcturner2 | |
05/10/2017 08:29 | Ticking up again. | greedy rooster | |
07/9/2017 08:24 | I bet they can't wait to have your support | greedy rooster | |
07/9/2017 08:04 | POST REMOVED | buywell3 | |
06/9/2017 10:47 | All the shares are Prophotonix - it's just that Sixh bought so many that they became an associate. Their shares then became subject to a restriction on selling in the US. Just because they are traded on the LSE as separate lines, they are equivalent in term of the company and rights. In a year's time, the PPIR line will once again vanish. | briangeeee | |
06/9/2017 09:12 | Results are due any day now, "early september" according to the trading update. | rcturner2 | |
05/9/2017 08:11 | POST REMOVED | buywell3 | |
05/9/2017 07:57 | The Miton RNS in the header is for PPIR shares 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: PROPHOTONIX LIMITED-REG S The Haergreave Hale RNS in the header is probably also for PPIR shares but is shown as 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: PROPHOTONIX LIMITED As no volume of PPIX shows then it is in error Likewise Herald is also probably an error 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: ProPhotonix Limited Likewise Gresham House Group 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: PROPHOTONIX LTD All of the above are for identical shares bought Why both appear on PPIX , when they are PPIR shares seems odd Looks to me like Miton are the only company who filled their TR-1: Standard form for notification of major holdings correctly Of course I could be wrong ... but I don't think so | buywell3 | |
05/9/2017 07:39 | Photonics division of IQE up 48% in interim results statement. Good to see quality new institutional investors on board snapping up the SIXH stake. | greedy rooster |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions